Sort   by:  
 Page size 
UnknownAvelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study.
Not available
S-EPMC5493051 | biostudies-literature
UnknownAvelumab for platinum-ineligible/refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck: phase Ib results from the JAVELIN Solid Tumor trial.
Not available
S-EPMC8524383 | biostudies-literature
UnknownA Phase II Study of Pelareorep (REOLYSIN®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma.
Not available
S-EPMC6025223 | biostudies-literature
UnknownEfficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer: Phase 1b Results From the JAVELIN Solid Tumor Trial.
Not available
S-EPMC6439837 | biostudies-literature
UnknownPhase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer.
Not available
S-EPMC7686313 | biostudies-literature
UnknownElectrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis.
Not available
S-EPMC8567307 | biostudies-literature
UnknownAdjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.
Not available
S-EPMC5538020 | biostudies-literature
UnknownAn international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs.
Not available
S-EPMC8811537 | biostudies-literature
UnknownX Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis.
Not available
S-EPMC8169555 | biostudies-literature
UnknownGenomic investigations of unexplained acute hepatitis in children.
Not available
S-EPMC10170458 | biostudies-literature
Sort   by:  
 Page size